title: Free vascularized fibular graft salvage of complications of long-bone allograft after tumor reconstruction.
abstract: BACKGROUND
  Long-bone allograft reconstruction following tumor extirpation can be complicated by problems such as nonunion at the host-allograft junction, allograft fracture, or allograft infection. Free vascularized bone grafts can be used to address these complications. The purpose of the current study was to examine retrospectively the outcomes and complications following allograft reconstruction salvage with onlay vascularized fibular grafts.
  
  
  METHODS
  A tumor registry review was conducted to identify all patients who underwent a reconstruction with a vascularized fibular graft for allograft reconstruction complications following tumor resection (host-graft nonunion, allograft fracture, or allograft nonunion) in the last nineteen years. The records of these patients were analyzed for details regarding the neoplasms and the treatment thereof, details of the free vascularized fibular graft reconstruction, time to osseous union, functional outcome, and clinical outcome.
  
  
  RESULTS
  Thirty-three patients satisfied the criteria for this study. The involved bones were the femur (eighteen patients), tibia (eight), and humerus (seven). Osseous union was achieved in all patients at a mean of 7.7 months. The average duration of follow-up was seventy-three months. Twenty-three patients achieved a good or excellent functional outcome. Ultimately, seven patients had a failure of the allograft reconstruction, which resulted in limb loss in five of them. Postoperative complications were relatively common in this series.
  
  
  CONCLUSIONS
  Free vascularized fibular grafting is a useful adjunctive surgical treatment for nonunion, fracture, and infection of an intercalary allograft reconstruction in limb salvage surgery. It has, however, a high rate of associated complications often resulting in failure.
authors.affiliation: Division of Hand and Microvascular Surgery, Department of Orthopedic Surgery, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905, USA.
authors.forename: Jeffrey B
authors.initials: JB
authors.lastname: Friedrich
authors.forename: Steven L
authors.initials: SL
authors.lastname: Moran
authors.forename: Allen T
authors.initials: AT
authors.lastname: Bishop
authors.forename: Christina M
authors.initials: CM
authors.lastname: Wood
authors.forename: Alexander Y
authors.initials: AY
authors.lastname: Shin
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D001859:Bone Neoplasms / Q000473:pathology / Q000601:surgery*; D016025:Bone Transplantation / Q000009:adverse effects* / Q000379:methods; D002648:Child; D005260:Female; D005269:Femur / Q000601:surgery; D005360:Fibula / Q000098:blood supply* / Q000637:transplantation*; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D006811:Humerus / Q000601:surgery; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011336:Probability; D019651:Plastic Surgery Procedures / Q000379:methods*; D012042:Registries; D012086:Reoperation; D012189:Retrospective Studies; D018570:Risk Assessment; D016879:Salvage Therapy; D013977:Tibia / Q000601:surgery; D014184:Transplantation, Homologous; D016896:Treatment Outcome